Skip to main content
    V

    Verrica Pharmaceuticals Inc (VRCA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.14
    -0.06 (-1.88%)

    Market Cap: $54.97M

    Last updated: Nov 17, 2026 at 4:32 PM ET

    Verrica Pharmaceuticals Inc (VRCA) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Verrica Pharmaceuticals (VRCA) has a latest price of $3.14 on Nov 17, 2026, 68.0% below its 52-week high of $9.82. Its price fell 20.1% over the past 12 months. The month-end price fell 98.3% since Jun 2018, a compound annual decline of 38.7%.

    Price Chart

    From Jun 2018 to Oct 2026, its highest month-end close was $197.30 in Jun 2018 and its lowest $3.35 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart VRCA with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for VRCA.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 37.1%, and over 6 months it fell 43.8%. The month-end price fell 90.9% over the 3 years through Oct 2026, a compound annual decline of 55.0%.

    PeriodChange
    1 month-8.7%
    3 months-37.1%
    6 months-43.8%
    12 months-20.1%
    12 months, with dividends-20.1%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-90.9%-55.0%
    5 years-97.3%-51.6%
    Since Jun 2018-98.3%-38.7%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2023, when the price rose 166.2%, and its weakest was 2024, when it fell 90.4%.

    YearCloseChange
    2026 through Oct 2026$3.35-59.7%
    2025$8.31+18.7%
    2024$7.00-90.4%
    2023$73.20+166.2%
    2022$27.50-70.0%
    2021$91.60-20.4%
    2020$115.10-27.6%
    2019$158.90+95.0%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 21.1% below its 50-day average of $3.98 and 41.5% below its 200-day average of $5.36.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$3.14
    52-week high$9.82-68.0%
    52-week low$3.08+1.9%
    50-day average$3.98-21.1%
    200-day average$5.36-41.5%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 96.8%.

    MeasureValue
    1-year beta2.23
    Largest fall, 1 year-66.0%
    Largest fall, 3 years-96.8%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About VRCA

    What is VRCA's 1-year price change?

    Verrica Pharmaceuticals's price fell 20.1% over the past 12 months. With dividends included, the 12-month total return was -20.1%.

    What is VRCA's 5-year price change?

    Verrica Pharmaceuticals's month-end price fell 97.3% over the 5 years through Oct 2026, a compound annual decline of 51.6%. These figures leave out dividends.

    What is VRCA's 52-week high and low?

    Verrica Pharmaceuticals's 52-week high is $9.82 and its 52-week low is $3.08. Its latest price of $3.14 on Nov 17, 2026 is 68.0% below the high.

    What is VRCA's beta?

    Verrica Pharmaceuticals's 1-year beta against the S&P 500 is 2.23, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 66.0%.

    Is the VRCA chart free?

    Yes. Advanced Charting for VRCA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.